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BIOTIPES OF AEROCOCCUS VIRIDANS 
 
SUMMARY 
A. viridans microorganisms are widespread in nature, they are representatives 
of the macro-microbiocenosis. There is evidence in the literature on the allocation of 
A. viridans during various diseases without an analysis of the immune status and the 
study of other possible pathogens that are the main cause of the disease. The 
presented in the literature genetic analysis of A. viridans took from the pathological 
focus does not gives us an opportunity to associate it with certain characteristics 
aerococcus. We conducted the research of excretion A. viridans from healthy 
macroorganisms and from the environment  to study their biological characteristics 
(for antibacterial compounds, the ability to produce reactive oxygen species, 
antioxidant system activity and antagonist activity). Based on these characteristics A. 
viridans were divided into three biotypes with strict compliance scientists features. 
Key words: aerococcus, biotypes, biochemical activity, аntioxidant protection. 
 
Formulation of the problem. Despite the fact that it is long time since the 
discovery and identification of aerococcus there is still no information about 
dissemination and characteristics of aerococcus takes part in the composition of 
microbial associations of endothermal animals.  For the first time aerococcus was 
sorted out in 1953 [42, 43], by the inoculation of the air, the air from the hospitals 
[33], soil [34]. 
Analysis of recent research and publications. Right after it was reported that 
aerococcus found in pathological material in the infectious process. A. viridans were 
isolated from the blood of patients with endocarditis [25, 28], from the urine of 
patients with urinary tract infection [31], from the blood of patients with 
hypogranulocytosis [24, 40].  
Aerococcus is prevalent in the animal microflora. The hemocultures of 
aerococcus were obtained from mice with bacterieamia [29]. It has been found that A. 
viridans is sensitive to penicilline, macrolide and chloramphenicol and resistant to 
aminoglycoside [26].  Were described the incidents of diseases in animals: pigs [36], 
cows’ mastitis [39], amphibious – turtles [40].  
The discovery of A. viridans in the focus of inflammation may not be 
indicative of their aetiological role without detailed bacteriological and virologic 
research of pathological material (disclosure or absence of Chlamydia or viruses).  
No study indicated the discovery of pathogenicity factors in aerococcus and attempts 
to simulate an experimental animal model of infection has not been successful [32].  
At the same time it was shown the wide representation of aerococcus in 
microbiocenosis of macroorganisms [18]. 
Biological treatment and prevention drugs, developed on the basis of A. 
viridans 167 [2, 7, 11, 19, 20] were separated from the human milk by the professor 
Gorbunova M. L. (1965) have demonstrated clinical efficacy in various pathological 
processes [21]. 
It has shown effectiveness for bacterial infection of the nasopharynx [4], 
increased immunoresponsiveness body [3, 15, 20] for preventing and treating 
salmonellosis [21], staphylococcal infection [13, 14, 16, 19] for control and 
normalization of the vaginal flora [ 18], the correction of dysbiosis and homeostasis 
of the organism [12], pulmonary tuberculosis [5], urologic complications of 
pathological processes [8], an antagonistic effect on the meningococcus [1]. 
Bold unsolved aspects of the problem. It has showed the intraspecific 
difference between aerococcus [17]. During studies at the molecular level in 
aerococcus (genetic characteristics, distribution of cell wall proteins during 
electrophoresis) have emerged a large number of aerococcus cultures with slight 
differences in characteristics assigned. This distribution is separated cultures do not 
allow to make the correlation between the molecular differences and their biological 
characteristics. 
The aim of the study. The object of our work is to try to spread the culture 
divided into two fundamental characteristics of A. viridans (the ability to oxidize 
lactate production of hydrogen peroxide and selenium reduction of its salt). 
Presenting main material. We studied gram-positive, catalase-negative cocci 
taken from biological material from healthy people, animals and birds, and delivered 
a comparative study to their taxonomic characteristics. 
It has been studied 118 aerococcus crops; taken from the human body, 16 
cultural objects taken from the environment (water, wash vegetables), 21 cultures 
taken from animals (mice - 10 aerococcus crops, pigs - 3 cultures, cows- 5 crops, 
chicken - 6 of Culture), a strain of sample preparation and bacterial-bacterine N and 4 
links aerococcus cultures. As reference cultures were used strains A. viridans from 
the collection SSM: №1911 [28, 32, and 41].  
Separation and identification of aerococcus cultures was held in the agreements 
methods offered by GN Kremenchutskiy et al (2009) [7].  
 For separation (gram+, gram- ) cocci was used fluid from the oral cavity of 
healthy people and faeces of animals and birds as biological material. Intake and held 
crop material and identifying microbial culture were made in accordance with [10]. 
To distinguish aerococcus forms on biochemical activity was developed an 
indicated medium, that includes sodium selenite. The following composition: 1 l of 
distilled water: potassium iodide - 26 g, soluble starch - 10 g, sodium selenite - 0, 4 g, 
dry nutrient medium - 32 g. The incorporation into the potassium iodide and soluble 
starch in medium makes it possible to evaluate the activity of oxidase aerococcus 
resulting color of the colonies in the culture medium as deep blue color. Aerococcus 
colonies that reduce sodium selenite in the selenium initial stain appear red. 
Sensitivity to antibiotics are evaluated by agar diffusion method using discs 
[10]. Aerococcus antagonistic action to the test cultures of microorganisms has been 
studied by the methods of deferred antagonism. 
Glutathione peroxidase activity was determined by the method of [9]. The 
protein was identified using the method of [34]. Superoxide was determined by the 
method of [36]. The activity of superoxide was identified by the method of [6]. SOD 
activity was expressed in micromoles / min. mg protein.  
During sowing crops aerococcus cultures separated on indicated media was 
noticed another color of the colonies and of the medium depending on the 
biochemical activity aerococcus. Culture, which oxidize potassium iodide sprouted 
colony with an intense dark color with dark coloring of the growth medium, the 
cultures were evaluated among 1 biotype aerococcus. Cultures that reduce selenium 
from sodium selenite colony sprouted, painted in red. These cultures were assessed as 
two biotypes aerococcus. Furthermore, it was observed that the growth of the 
colonies colored red with fade out within the area around the medium indicates the 
oxidation of potassium iodide and at the same time reducing selenium from sodium 
selenite about.  
These cultures were rated as 3 biotype of aerococcus.( Pic.1) Distribution of 
separated cultures from different sources by biotypes is shown in Tab. 1 
 
                                
Pic. 1. Three biotypes Aerococcus viridans: 
a) Black colonies – 1 biotype, red – 2 biotype of aerococcus; 
b) Red colonies with black zones – 3 biotype. 
 
Table 1  
The distribution of crops on the forms of biochemical 
 activity, depending on the emission source  
Source of the 
release 
Quantity of examined 
aerococcus cultures 
 
Distrobution of cultures on forms of biochemical activity 
Oxidation KJ 
(1 type) 
Reduce of Na2SeO3 
(2 type) 
Both types of 





1911 + - - 
1914 - + - 
2439 +   
2440, - + - 
2452 + - - 
human Strain for production 
A-bacterine № 167 
1 0 0 
human 30 17 6 7 
birds 23 22 3 10 
cows 6 1 0 1 
sheep 5 2 4 1 
pigs 7 4 3 0 
mice 10 6 2 2 
air 5 4 2 1 
water 23 19 2 2 
A study of sensitivity of aerococcus strains to antibiotics of penicillin row and 
lysozyme was conducted on the samples, which aim is the cell walls of aerococcus. 
Details of these experiments in Table. 2 
From the data of Table 2 can be seen the clear difference in the effect of 
antibiotics penicillin and lysozyme row, which shows the existence of the 
characteristic in the structure of cell walls 2, 1 and 3 biotypes.  
Tab.2 










Previously we have seen that aerococcus ROS production is a result of the 
oxidation of lactic acid, glycerol phosphate, glycine. To account for the production of 
ROS aerococcus antagonize as for pathogenic and opportunistic microorganisms. 
Table 3 shows the results of experiments on the detection of superoxide anion 
production and hydrogen peroxide bio. A. viridans.  
Antioxidant protection of aerococcus cells comes true by functioning 
superoxide dismutase, glutathione peroxidase, also chemical reaction between 
hydrogen peroxide with pyruvic acid, that form lactic acid. In the tab. 4 are showed 
the characteristics of superoxide dismutase and GSH-peroxidase activity of biotypes 
A. viridans. 
Antioxidant protection of aerococcus cells exist by functioning of superoxide 
dismutase, glutathione peroxidase, and a chemical reaction between the hydrogen 




































peroxide with pyruvate to produce lactic acid. Table. 4 shows the characteristics of 
SOD and GSH-peroxidase activity biotypes A. viridans. 
Tab. 3 
Production of superoxide anion and hydrogen peroxide in the course of 




Superoxide dismutase and GSN-peroxide activity of biotypes A. viridans  
Biotypes Specific activity of superoxide 
dismutase ED 1 mg of protein for 
1 min 
Specific activity GSH-peroxide 
ED on 1 mg of protein for 1 
min 
1 type 5,45±0,7 0,44±0,04 
2 type 8,351,02 0,95±0,23 
3 type 12,1 ± 0,9 5,6± 0,26 
 
Antagonistic activity of  representatives of different biotopes A. viridans for 
catalase-negative strain of Vibrio NAG and catalase-positive E. coli with lactate 
oxidase activity and the accumulation of hydrogen peroxide at the time of growth 
medium were compared. (tab. 5) 
These data show the production of biologically active substances of different 
biotypes A. viridans: hydrogen peroxide, superoxide, lactate oxidase, superoxide 
dismutase and GSH-peroxidase. 
 
Biotypes Specific activity of 
production superoxide 
(О-2) on 1 mg of protein 
FK by 1 min 
Influence on the 




hydrogen peroxide in 
broth , mM  
 
1 type 13,8 ± 0,97 1,7 ±0, 3 4,2+0,8 
2 type 1,350,02 0,95±0,23 0,08+0,001 
3 type 8,1± 0,9 5,6 ± 0,26 2,3,3+0,06 
Tab. 5 
Comparison of antagonistic and oxydase activity  
in different types of aerococcus 
Biotypes Biological activity of aerococcus strains 
Diameter of zone of 
the suppression the 
growth of Vibrio 
NAG (mm) 
Diameter of zone of 
the suppression the 
growth of Е. соli, 
(mm) 
Activity of 




peroxide in broth 
(mM) 
1 type 37,2±3,4 12,1±1,2  1112±87 4,2±0,8  
2 type 18,2±5,1 5,0±1,2 231±211  0,08±0,001 
3 type 47,5±5,6  15,7±4,3  714±15 2,3,3±0,06 
 
Information in the tables indicate that biotypes 1 and 3 of A. viridans at the 
time of equimolar production of adenosine phosphosphoric acid have a stronger 
antagonistic effect than catalase-negative strains of Vibrio NAG and catalase-positive 
E.coli. The antagonistic effect of biotype 2 Aerococcus viridans for catalase-negative 
strain Vibrio AG and catalase-positive E.coli during decreased activity of lactate 
oxidase and virtually zero production of hydrogen peroxide can be explained by the 
additional substances such antagonistic microsin, produced by aerococcus, 
Despite the significant concentration of adenosine phosphoric acid produced by 
aerococcus is grows on ordinary nutrient media, and they are ubiquitous 
representatives of the normal microflora and microorganisms. These facts suggest 
about the balanced intracellular redox regulation of aerococcus. 
 
Conclusions and suggestions. Microorganisms of the genera Aerococcus, 
A.viridans species are widely distributed in biotype and healthy macroorganisms, in 
the environment, and can be divided into three biotypes whose members differ in 
their sensitivity to penicillin and lysozyme by their ability to oxidize the lactic acid 
production APA reduce selenium from selenite sodium. Activities of A.viridans 
antioxidant system (catalase, superoxide dismutase and glutathione peroxidase) 
biotypes differ depending on the intensity of production of APA. 
There is a correlation between oxidative activity A. viridans and antagonistic 
activity of representatives of three biotypes for catalase-negative Vibrio NAB and 
catalase-positive E.coli.  
Taking into account the antagonistic effect of A. viridans type 2 catalase 
positive E. coli it may be assumed that there is an additional mechanism for the 
production of antibacterial factor 
 
LITERATURE 
1. Антагоністична активність пробітиків А-бактерину та 
біоспорину у відношенні N.meningitidis / Риженко С.А., Прядко Л.О., Дікленко 
Т.М., Хейлік О.Г. // Мед. перспективи. - 2003. – Т. 8, № 3. - С. 84-86.) 
2. А-бактерин – пробіотик нового покоління / Риженко С.А., 
Кременчуцький С.Г., Ісаєв А.В., Юргель Л.Г., Кулішенко С.Г.// Буков. мед. 
вісн. - 2002. - Т. 6, № 3. - С. 232-234 Біологічні властивості А-бактерину / 
Риженко С.А., Кременчуцький С.Г., Черняєв С.А., Кулішенко С.Г. // Вісн. Сум. 
держ. ун-ту. -2001.- № 11(32) - С. 159-168.  
3. Влияние живой культуры Aerococcus viridans на факторы 
иммунологической реактивности организма человека in vitro 
/ Кременчуцький Г.Н., Кулишенко С.Г., Рыженко С.А., Вальчук С.И., 
Юргель Л.Г., Бицкий В.В., Лахтионова Н.Г., Шарун О.В. // Материалы XI мед. 
конф. «Новые информационные технологии в медицине, биологии, 
фармакологии, экологии». – Гурзуф, 2003. – С. 370-374  
4. Изучение влияния профилактического приема А-бактерина 
детям раннего возраста с персистирующей бактериальной инфекцией 
носоглотки / Шарун И.Э., Шарун А.В., Мединская О.Н., Рыженко С.А. 
// Междунар. конф. «Новые информационные технологи в клинической 
нейрофизиологии неврологии и хирургии». – Гурзуф, 2001. – С. 202-201.  
5. Кожушко М.Ю., Риженко С.А. Антитоксична дія А-бактерина у 
хворих на туберкульоз легень // Мед. перспективи. - 2003. – Т.8, № 2. - С. 69-
71.  
6. Костюк В. А., Потапович А.И., Ковалева Ж.В. Простой и 
чувствительный метод определения активности супероксиддисмутазы, 
основанный на реакции окисления кверцетина // Вопр. мед. химии. - 1990. - № 
2. - С. 88-91. 
7. Кременчуцкий Г.Н,  Юргель Л.Г., Шарун О.В., Степанский Д.А., 
Вальчук СІ., Кошева І.П, Парусов А.В.- Методичні рекомендації.-Київ. - 2009.-
19 с.  
8. Кутовий А.Б., Риженко С.А., Молчанов Р.М., Вальчук С.І. // 
Урология. – 2003. – Т.7, № 1 - С. 23-25 Антагоністична активність пробітиків 
А-бактерину та біоспорину у відношенні N.meningitidis / Риженко С.А., 
Прядко Л.О., Дікленко Т.М., Хейлік О.Г. // Мед. перспективи. - 2003. – Т. 8, 
№ 3. - С. 84-86.  
9. Моин.В.И. Простой и чувствительный метод определения 
глутатионпероксидазы в эритроцитах // Лаб. Дело.-1986.-№12-С. 724-727  
10. Об унификации микробиологических методов исследования, 
применяемых в клинико-диагностических лабораториях лечебно-
профилактических учреждений. Приказ№ 535 МЗ СССР от 22.04.1985. М., 
1985. 56 с  
11. Риженко С.А. Вплив А-бактерину при пероральному прийомі 
на показники білкового і ліпідного обміну організму людини // Вісн. Вінниц. 
держ. мед. ун-ту. - 2002. - Т. 6, № 1. - С. 83-84.  
12. Риженко С.А. Корекція мікробіоценозу кишечнику пробіотиком А-
бактерин у хворих на дизбактеріоз // Мед. перспективи. - 2001. - Т.6, № 4. - 
С. 75-77.  
13. Риженко С.А. Особливості антагоністичної дії Aеrососсus viridаns 
на Staphylococcus aureus in vitro при повторному контакті // Укр. мед. 
альманах. - 2003. - № 1. - С. 101-103  
14. Риженко С.А. Про зміну чутливості до пеніциліну Staphylococcus 
aureus при спільному культивуванні з Aеrососсus viridаns in vitro // 
Дерматология, косметология, сексопатология. – 2002. - № 3-4(5). - С. 58-60  
15. Риженко С.А., Вальчук С.І. Вплив живої культури Aerococcus 
viridans на фактори імунологічної реактивності організму людини in vitro 
// Одес. мед. журн. – 2003. - № 5 (79). – С.108-111. 
16. Риженко С.А., Вальчук С.І., Шарун О.В. Активність каталази 
Staphylococcus aureus при спільному культивуванні з Aеrососсus viridаns in 
vitro // Медицина сьогодні і завтра. - 2003. - № 1. - С. 40-42  
17. Риженко С.А., Черняєв С.А., Кременчуцький С.Г. Зміна біологічних 
властивостей усередині популяції Aerococcus viridans // Мед. перспективи. - 
2002. - Т.7, № 2. - С. 18-21...). Методи виділення та ідентифікації грам 
позитивних каталазо негативних коків.   
18. Риженко С.А., Юргель Л.Г., Шарун О.В. Динаміка показників 
мікробіоценозу піхви у вагітних і породілей // Мед. перспективи. - 2004. –Т.9, 
№ 2. - С.79-81.  
19. Риженко С.А., Вальчук С.І., Шарун О.В. Дослідження 
лікувальної дії Aеrососсus viridаns на моделі стафілококової інфекції // Мед. 
перспективи. - 2003. – Т.8, № 1. - С.34-36.  
20. Риженко С.А., Кулішенко С.Г., Журило О.А. Імунні реакції 
організму людини на пробіотик А-бактерин // Вісн. фармації. - 2002. - № 4. -
 С. 78-80.  
21.  Рыженко С.А. Влияние А-бактерина на гомеостаз организма 
человека при различных патологических состояниях // Сб. материалов 
междунар. науч.-практ. конф. памяти Г.И. Гончаровой «Пробиотические 
микроорганизмы – современное состояние вопроса и перспективы 
использования» / Под ред. В.А. Алешкина. – М., 2002. – С. 41-42. 
22.  Рыженко С.А. Влияние пробиотика А-бактерина на повторное 
бактериовыделение, выраженность интоксикации и течение сальмонеллезов // 
Вестн. гигиены и эпидемиологии. - 2002. - № 1. - С. 63-66.  
23.  Рыженко С.А., Кременчуцкий Г.Н. Эффективность А-
бактерина при пероральном и наружном применении // Междунар. конф. 
«Новые информационные технологии в клинической нейрофизиологии, 
неврологии и хирургии». – Гурзуф, 2001. – С. 99-100. 
24.  Battison AL, Cawthorn RJ, Horney B  Response of American lobsters 
Homarus americanus to infection with  field isolate of Aerococcus viridans var. 
homari (Gaffkemia): survival and hematology. Dis Aquat Organ.-2004.-61,№3.-Р. 
263-268.  
25. Bru, P., C. Manuel, C. Iacnnn, A. Vaillant, C. Malmejac, and J. 
Houel. 1986. Indications and result of surgery in native valve infectious 
endocarditis. Apropos of 104 surgically-treated cases. Arch. Mai. Coeur Vaiss. 
79:47-51. 
26.  Buu-Hoi, A. C., C. Le Bouguenec, and T. Horaud. 1989. Genetic basis 
of antibiotic resistance in Aerococcus viridans. Antimicrob. Agents Chemother. 
33:529-534. Public Health Agency of Canada. (2004). 
27. Cetin M, Ocak S, Ertunc D. a case report unusual case of urinary 
tract infection caused by Aerococcus viridans.. Med. Sci. Monit .- 2007;21:65-67  
28. Clausen, O.G. 1964. The discovery, isolation, and classification of 
various alpha-haemolytic micrococci which resemble aerococci sp. nov. J. Gen. 
Microbiol. 35 : 1-8.  
29.  Dagnaes-Hansen F, Kilian M, Fuursted K (2004) Septicaemia 
associated with an Aerococcus viridans infection in immunodeficient mice. Lab 
Anim 38: 321-325  
30.  Gopalachar A, Akins RL, Davis WR, Siddiqui AA (2004)Urinary 
tract infection caused by Aerococcus viridans. 
31.  In Best M., Graham M. L., Leitner R., Ouellette M. and Ugwu K. (Eds.), 
The Laboratory Biosafety Guidelines (3rd ed.). Canada Stewart JE, Cornick JW, 
Zwicker BM, Arie B (2004) Studies on the virulence of Aerococcus viridans (var.) 
homari, the causative agent of gaffkemia, a fatal disease of homarid lobsters. Dis 
Aquat Organ 60: 149-155. 
32. Kerbaugh, M. A., and J. B. Evans. Aerococcus viridans in the hospital 
environment. Appl. Microbiol. 1968.- 16:519-523.  
33. Kontehou, C. Y., and R. Blondeau. 1990. Isolation and 
characterization of hydrogen peroxide producing Aerococcus sp. from soil samples. 
FEMS Microbiol. Lett. 68:323-328. 
34. Lowry O.H. Protein measurement with the folin phenol reagent / 
O.H. Lowry // Biol. Chem. – 1951. – Vol. 193, № 1. – P. 265–275. 
35.  Martin V, Vela AI, Gilbert M, Cebolla J, Goyache J, Dominguez 
L, Fernandez-Garayzabal JF (2007) Characterization of Aerococcus viridans 
Isolates from Swine Clinical Specimens.J Clin Microbiol 45: 3053-3057.  
36. Pigeolet E., Corbisier P., Houbion A., Lambert D. et al. Glutathione 
peroxidase, superoxide dismutase, and catalase inactivation by peroxides and 
oxygen derived free radicals // Mech Ageing Dev. - 1990- Vol..51, No 3. - P. 283-
297.). 
37.   Popescu GA, Benea E, Mitache E, Piper C, Horstkotte D (2005) An 
unusual bacterium, Aerococcus viridans, and four cases of infective endocarditis. J 
Heart Valve Dis 14: 317-319.  
38. Spakovaґ T., Elecko J., Vasil M., Legaґth J., Pristas P., Javorskyґ  
P. Limited genetic diversity of Aerococcus viridans strains isolated from clinical 
and subclinical cases of bovine mastitis in Slovakia Polish Journal of Veterinary 
Sciences Vol. 15, No. 2 (2012), 329-335  
39. Torrent A, Deniz S, Ruiz A, Calabuig P, Sicilia J, Oros J (2002) 
Esophageal diverticulum associated with Aerococcus viridans infection in a 
loggerhead sea turtle (Caretta caretta). J Wildl Dis 38: 221-223. 
40. Uh, Y., Son, J. S., Jang, I. H., Yoon, K. J., & Hong, S. K. 
Penicillin-resistant Aerococcus viridans bacteremia associated with 
granulocytopenia. Journal of Korean Medical Science.-2002.- 17(1), 113-115  
41. Williams, R.E.O., Hirch, A., and Cowan, S.T. Aerococcus, a new 
bacterial genus. J.Gen. Microbiol., 1953, Vol. 79,№8, 475-480.  
 
 
